Endo2 Flashcards
(53 cards)
What are the priorities of diabetic management?
- Relieve symptoms of hyper
- Avoid complications of hyper (including DKA, hyperosmolar hyperglycaemic states)
- Avoid Hypoglycaemia
- Manage and reduce severity of long term complications
What are 12 key steps in Diabetes management? What if ths patient is ATSI?
- Build an exercise plan
- Build a healthy eating plan
- STOP smoking
- Reduce alcohol
- Manage Co-morbidities- HTN, Lipids, Obesity management (Reduce CV risk)
- Manage psychological issues
- Educate about disease, self monitoring, ADR of drugs, Complications, intercurrent illness, travelling, driving, hypoglycaemia and its management
- Start hypoglycaemic meds - tablets or insulin
- SCREEN for complications and treat
- All DM under 65 should be testsed for LTBI (using Interferon gamma release assay - IGRA)
- PneumoVax - Prevenar 13 at diagnosis, 1-12months later give 23vPPV, then 3rd dose at 5 years of 23vPPV
- Yearly influenza vaccination
ATSI - INVOLVE ABORIGINAL HEALTH WORKER
When is self monitoring of blood glucose recommended?
- Insulin
- Sulfonylureas
- If sugars are labile and difficult to control
(Usually not recommended for T2 on orals)
What is the target HBA1c and what are the upper and lower limits?
7%
more stringent - 6.5
more relaxed - 8%
Young, newly diagnosed, long life expectancy and few comorbidities - 6.5
Old, many comorbidities, does not want extra drug burden - 8
What are the fasting and post prandial blood sugar targets in DM?
Fasting: 4-7
PP: 5-10
IN PAL CARE = 6-15 target
BP target in DM?
140/90
Target lipids in DM?
Fasting - less than 4
LDL - 2 (1.8 in secondary prev)
TG - 2
HDL - 1
When would you start a diabetic patient on lipid management?
ONLY according to CVS risk calculation
What are the Urine - Albumin/Creatinine ratio targets in diabetes
Men less than 2.5
Women less than 3.5
BMI targets in DM?
Advise - 5-10% weight loss
IF BMI > 35 with comorbidities OR > 40 - greater weight loss is needed
What vaccinations are recommended for T2DM?
- Influenza
- Pneumococcal (prev13 at dx, dose 2 (1-12months later), dose 3 5 years later.
- Boostrix DTPa
CONSIDER:
a) Hep B (if travelling)
b) Herpes Zoster
How much change in HBA1c can be seen with dietary changes?
1 to 2 % decrease
What are exercise recommendations in Diabetes?
What are exercise recommendations for weight reduction?
- 150minutes of moderate intensity aerobic activity per week, 30 minutes on most days of the week. PLUS 2-3 sessions of resistance activity (to a total of 60 minutes)
- Weight reduction (double) - 300minutes - 1hr on most days of the week
Brisk walking - moderate intensity
What are recommendations for exercise for children/adolescents with diabetes?
60 minutes mod/high intensity exercise EVERY DAY
PLUS bone and muscle strengthening activities at least 3 days/week
Precautions when commencing diabetic patients on exercise program?
- Comorbidities - IHD and lower limb injury (if foot issues - may need podiatry review first)
- Are they on insulin? - if so need to alter dosage pre and post exercise and ensure adequate CHO intake to reduce Hypo risk
Dietary recommendations in Diabetes?
5-10% weight loss improves glycaemic control
Overall caloric intake is more important than style of eating
A 600kcal (2500kjoule) caloric deficit would help in weight reduction
Recommend - high fibre low glycaemic index carbs, oily fish high in Omega 3 fatty acids, polyUNsaturated FA and monoUNsaturatef FA’s are better than Saturated FAs
Dietary guidelines advice - 5 food groups (proteins, dairy, grains/cereals, veg, fruit) and plenty of water
limit added salt, added sugar and saturated fat
Side effects of biguanides/metformin?
can cause:
gastrointestinal adverse effects
vitamin B12 deficiency
lactic acidosis (rare)
reduce dose in patients with kidney impairment
Sideeffects of sulfonylureas?
can cause:
weight gain
significant hypoglycaemia, especially in older patients (glibenclamide, glimepiride)
avoid in patients with kidney impairment (glibenclamide, glimepiride)
Side effefcts of DPP-4i medications? eg linagliptin
hypoglycaemia unlikely [NB3]
no weight gain
improve postprandial glucose control
safe in patients with cardiovascular disease (except saxagliptin and possibly alogliptin)
Side effects of GLP-1 RAs?
eg liraglutide, exenatide
avoid in patients with:
acute pancreatitis or history of pancreatitis
family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (liraglutide)
can cause gastrointestinal adverse effects (often transient)
avoid in patients:
with severe kidney impairment (dulaglutide, exenatide)
with end-stage kidney disease (liraglutide)
Side effects of SGLT2 inhibitors?
Eg Empagliflozin, dapagliflozin
avoid in patients:
periprocedurally
who are fasting
who are on very low-carbohydrate diets
can cause:
genitourinary infection
reversible increase in creatinine
volume depletion (rare)
diabetic ketoacidosis (uncommon), which may occur without hyperglycaemia
reduced glycaemic efficacy with kidney impairment
SIde effects of insulin?
can cause:
significant hypoglycaemia
weight gain
only available as parenteral formulations

Evidence of specific autoimmune diseases such as vitiligo on examination **Postablative therapy or surgery** Radioiodine therapy Thyroidectomy History of previous radioiodine therapy or thyroid surgery
Evidence of a surgical scar or skin changes suggestive of previous external neck irradiation on examination **Transient** Subacute thyroiditis Silent thyroiditis Postpartum thyroiditis Early postablative therapy Preceding history of viral infection, pregnancy or radioiodine ablation
Evidence of an enlarged tender thyroid on examination (subacute thyroiditis) **Iodine associated** Iodine deficiency Iodine induced Dietary intake history **Drug induced** Carbimazole Propylthiouracil Iodine Amiodarone Lithium Interferons Thalidomide Sunitinib Rifampicin *Medication history* **Infiltrative** Riedel thyroiditis (fibrous thyroiditis) Scleroderma Amyloid disease Haemochromatosis Infection (eg. tuberculosis) Personal history or other systemic features of an infiltrative disorder **Neonatal/congenital** Thyroid agenesis/ectopia Genetic disorders affecting thyroid hormone synthesis Transplacental passage of TSH receptor blocking antibody Family history of thyroid disease/hypothyroidism
Maternal medication use during pregnancy **Rare** Thyroid agenesis/ectopia Secondary (pituitary or hypothalamic disease) Thyroid hormone resistance syndrome Anomalous laboratory TSH results (eg. caused by heterophil antibodies) Other clinical features of pituitary deficiency